Impact of Community Health Worker Home Deployment on COVID-19 Vaccine Confidence and Uptake
Project Number3P30DK111024-06S1
Former Number5P30DK111024-05
Contact PI/Project LeaderNARAYAN, KABAYAM M VENKAT
Awardee OrganizationEMORY UNIVERSITY
Description
Abstract Text
PROJECT SUMMARY / ABSTRACT
In response to NOT-OD-21-101, the Georgia Center for Diabetes Translation Research (P30DK111024-05S1),
a partnership of Emory University (EU), Morehouse School of Medicine (MSM), and Georgia Institute of
Technology submits this RADx-UP Supplement proposal titled, “Impact of Community Health Worker Home
Deployment on COVID-19 Vaccine Confidence and Uptake.” We propose collaborating with our RADx-UP
Diabetes rural community partner and utilizing locally developed and tested Georgia CEAL (1OT2HL156812-
01/16-312-0217571-66105L, PI-Akintobi) COVID-19 communication materials to enhance COVID-19 testing in
addition to vaccine confidence and uptake in underserved populations most severely affected by COVID-19
disease (i.e., African Americans and Latinos with diabetes, prediabetes, and their household contacts
[“bubble”]). The proposed 1-year project will implement and evaluate a brief Community Health Worker (CHW)
intervention through the Albany Area Primary Health Care, a rural Federally Qualified Health Center (FQHC).
The primary goal of this study is to maximize effective outreach, education, and communication through CHWs
in order to facilitate improved COVID-19 vaccine confidence and uptake in underserved and vulnerable
communities. CHWs will be deployed to the homes of adults with increased risk of morbidity and mortality (i.e.,
African Americans or Latinos with uncontrolled diabetes or prediabetes, age <50 years, and non-COVID-19
vaccinated) in order to educate them about diabetes, COVID-19 and related vaccines. Health assessments,
including blood glucose measurement, will be conducted on the indexed patient and offered to all other adult
family members in the household (i.e., “bubble”). Adults with Type 2 diabetes likely live in households with
other adults who have or are at increased risk for diabetes (i.e., prediabetes and obesity).1 It is expected that
they will also share similar COVID-19 exposure risk. The specific aims are to: 1) Evaluate a community-driven
education program to increase and enhance COVID-19 vaccine confidence and uptake in individuals with
uncontrolled diabetes and their families (i.e., their “bubble”) and 2) Evaluate a community-driven education
program to improve diabetes self-management behaviors and related outcomes (e.g., blood glucose) in
individuals with uncontrolled diabetes in rural, Southwest Georgia.
Public Health Relevance Statement
PROJECT NARRATIVE
Given the elevated risk of severe disease, it is imperative that those with diabetes and prediabetes receive
COVID-19 testing, vaccines, and follow recommended guidelines for disease management and/or risk
reduction. We will leverage our RADx-UP Diabetes partnership with Albany Area Primary Health Care and its
networks to apply evidence-based approaches to evaluate the feasibility of rural area FQHC CHWs to improve
diabetes outcomes, COVID-19 vaccine confidence and uptake among adults diagnosed with diabetes and their
“bubble.” As with the RADx-UP Diabetes parent project, this supplemental project will also be guided by the
EPIS framework, which considers the multilevel nature of healthcare, organizations within systems, and patient
needs.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AdultAffectAfrican AmericanAgeAreaAttitudeAwardBehaviorBeliefBlood GlucoseCOVID-19COVID-19 testingCOVID-19 vaccineCommunicationCommunitiesCommunity Health AidesCommunity Health SystemsCountyDiabetes MellitusDiagnosisDiseaseDisease ManagementEcosystemEducationEvaluationFamilyFamily memberFederally Qualified Health CenterGoalsGovernmentGuidelinesHealthHealthcareHomeHouseholdIndividualInfrastructureInstitutesInterventionLatinoLeadershipMeasurementMorbidity - disease rateMorehouse School of MedicineNatureNeighborhood Health CenterNon-Insulin-Dependent Diabetes MellitusObesityOutcomeParentsPatientsPediatric HospitalsPrediabetes syndromePrevention strategyPrimary Health CarePublic HealthRADxRADx Underserved PopulationsResearch PersonnelRiskRisk ReductionRuralRural CommunitySystemTechnologyTestingTranslational ResearchTranslationsUnderserved PopulationUniversitiesVaccinatedVaccinesbehavior changecommunity engagementcomorbiditydesigndiabetes riskdiabetes self-managementevidence basehealth assessmenthealth care service organizationhigh risk populationimprovedindexingmortalitynext generationoutreachparent projectprogramsresponserural areauptakevaccine acceptance
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
847
DUNS Number
066469933
UEI
S352L5PJLMP8
Project Start Date
16-September-2016
Project End Date
31-July-2024
Budget Start Date
27-August-2021
Budget End Date
31-July-2024
Project Funding Information for 2021
Total Funding
$300,000
Direct Costs
$281,966
Indirect Costs
$18,034
Year
Funding IC
FY Total Cost by IC
2021
NIH Office of the Director
$300,000
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 3P30DK111024-06S1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3P30DK111024-06S1
Patents
No Patents information available for 3P30DK111024-06S1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3P30DK111024-06S1
Clinical Studies
No Clinical Studies information available for 3P30DK111024-06S1
News and More
Related News Releases
No news release information available for 3P30DK111024-06S1
History
No Historical information available for 3P30DK111024-06S1
Similar Projects
No Similar Projects information available for 3P30DK111024-06S1